Gerber Kawasaki Wealth & Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$539K	Sell	1,074 -166	-13%	-$79.7K	0.01%	227
2026 Q1	$610K	Sell	1,240 -101	-8%	-$54.8K	0.02%	202
2025 Q4	$777K	Sell	1,341 -7	-0.5%	-$3.96K	0.03%	172
2025 Q3	$654K	Sell	1,348 -441	-25%	-$205K	0.02%	186
2025 Q2	$726K	Sell	1,789 -260	-13%	-$109K	0.03%	167
2025 Q1	$1.02M	Sell	2,049 -24	-1%	-$13K	0.05%	136
2024 Q4	$1.08M	Sell	2,073 -83	-4%	-$45.6K	0.05%	136
2024 Q3	$1.33M	Sell	2,156 -118	-5%	-$69.9K	0.06%	123
2024 Q2	$1.26M	Sell	2,274 -317	-12%	-$182K	0.06%	123
2024 Q1	$1.51M	Sell	2,591 -791	-23%	-$444K	0.08%	115
2023 Q4	$1.8M	Sell	3,382 -983	-23%	-$476K	0.11%	104
2023 Q3	$2.21M	Sell	4,365 -859	-16%	-$458K	0.15%	89
2023 Q2	$2.72M	Sell	5,224 -182	-3%	-$98.2K	0.18%	84
2023 Q1	$3.12M	Sell	5,406 -908	-14%	-$512K	0.25%	74
2022 Q4	$3.48M	Sell	6,314 -1,051	-14%	-$557K	0.31%	69
2022 Q3	$3.75M	Buy	7,365 +187	+3%	+$105K	0.35%	58
2022 Q2	$3.9M	Sell	7,178 -167	-2%	-$91.9K	0.37%	58
2022 Q1	$4.34M	Sell	7,345 -54	-0.7%	-$31K	0.35%	49
2021 Q4	$4.89M	Buy	7,399 +1,088	+17%	+$679K	0.39%	49
2021 Q3	$3.61M	Buy	6,311 +2,075	+49%	+$1.14M	0.47%	39
2021 Q2	$2.14M	Buy	4,236 +544	+15%	+$257K	0.22%	75
2021 Q1	$1.68M	Buy	3,692 +671	+22%	+$320K	0.2%	77
2020 Q4	$1.41M	Buy	3,021 +427	+16%	+$200K	0.19%	70
2020 Q3	$1.15M	Buy	2,594 +113	+5%	+$46.7K	0.24%	56
2020 Q2	$898K	Sell	2,481 -455	-15%	-$153K	0.2%	68
2020 Q1	$832K	Buy	+2,936	New	+$926K	0.24%	65

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's TMO Position: Q2 2026 in Review

Gerber Kawasaki Wealth & Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, selling an estimated $79.7K and leaving 1,074 shares worth $539K. The position accounts for 0.01% of the portfolio, ranked #227.

Gerber Kawasaki Wealth & Investment Management first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $4.89M in Q4 2021. 1,922 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Gerber Kawasaki Wealth & Investment Management held 1,074 shares of Thermo Fisher Scientific worth $539K as of Q2 2026.
Gerber Kawasaki Wealth & Investment Management sold 166 Thermo Fisher Scientific shares in Q2 2026, an estimated $79.7K.
Thermo Fisher Scientific made up 0.01% of Gerber Kawasaki Wealth & Investment Management's portfolio in Q2 2026, its #227 holding.
Gerber Kawasaki Wealth & Investment Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
Gerber Kawasaki Wealth & Investment Management's Thermo Fisher Scientific position peaked at $4.89M in Q4 2021.
1,922 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.